Valeant Pharma (VRX) Receives Subpoena from California Department of Insurance

Valeant Pharma (NYSE: VRX) disclosed the following in its Form 10-Q on Wednesday:

Investigation by the California Department of Insurance

On or about September 16, 2016, the Company received an investigative subpoena from the California Department of Insurance. The materials requested include documents concerning the Company’s former relationship with Philidor and certain California-based pharmacies, the marketing and distribution of its products in California, the billing of insurers for its products being used by California residents, and other matters. The Company is cooperating with this investigation. The Company cannot predict the outcome or the duration of this investigation or any other legal proceedings or any enforcement actions or other remedies that may be imposed on the Company arising out of this investigation.

You May Also Be Interested In

• Century Therapeutics names Joseph Truitt to its board of directors
• USA Compression Partners launches $600M senior notes offering
• Zenta Group to acquire ZentoAI in cash and stock deal